Roel Bogie

Molecular pathways in post-colonoscopy versus detected colorectal cancers: Results from a nested case-control study

29. van Buuren S, Groothuis-Oudshoorn K. MICE: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software. 2011;45(3):1-67. 30. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2015. 31. Dorenkamp S, Mesters I, Schepers J, . . . de Bie R. Disease Combinations Associated with Physical Activity Identified: The SMILE Cohort Study. Biomed Res Int. 2016;2016:9053578. 32. Finch H. Comparison of distance measures in cluster analysis with dichotomous data. Journal of Data Science. 2005;3(1):85-100. 33. Warnes GR, Bolker B, Bonebakker L, . . . Venables B. gplots: Various R Programming Tools for Plotting Data. R package version 3.0.1 ed2016. 34. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330-7. 35. Stoffel EM, Erichsen R, Froslev T, . . . Baron JA. Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study. Gastroenterology. 2016. 36. Cisyk AL, Penner-Goeke S, Lichtensztejn Z, . . . McManus KJ. Characterizing the prevalence of chromosome instability in interval colorectal cancer. Neoplasia. 2015;17(3):306-16. 37. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396(6712):643-9. 38. Simons CC, Hughes LA, Smits KM, . . . van Engeland M. A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. Ann Oncol. 2013;24(8):2048-56. 39. JE IJ, Medema JP, Dekker E. Colorectal neoplasia pathways: state of the art. Gastrointestinal endoscopy clinics of North America. 2015;25(2):169-82. 40. Fearon ER, Carethers JM. Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome. Gastroenterology. 2015;148(1):10-3. 41. Shaukat A, Arain M, Thaygarajan B, Bond JH, Sawhney M. Is BRAF mutation associated with interval colorectal cancers? Dig Dis Sci. 2010;55(8):2352-6. 42. Hoffmeister M, Blaker H, Jansen L, . . . Brenner H. Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case Control Study. Am J Gastroenterol. 2020;115(12):2007 16. 43. Okamoto K, Kitamura S, Kimura T, . . . Takayama T. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: Current status and management. Journal of gastroenterology and

hepatology. 2017;32(2):358-67. 44. Pohl H, Srivastava A, Bensen SP, . . . Robertson DJ. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013;144(1):74-80 e1. 45. Bettington M, Walker N, Rosty C, . . . Whitehall V. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut. 2017;66(1):97-106. 46. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138(6):2088-100. 47. Voorham QJ, Rondagh EJ, Knol DL, . . . Sanduleanu S. Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta analysis. Am J Gastroenterol. 2013;108(7):1042-56. 48. Voorham QJ, Carvalho B, Spiertz AJ, . . . Meijer GA. Comprehensive mutation analysis in colorectal flat adenomas. PLoS One. 2012;7(7):e41963. 49. Konda K, Konishi K, Yamochi T, . . . Yoshida H. Distinct molecular features of different macroscopic subtypes of colorectal neoplasms. PLoS One. 2014;9(8):e103822. 50. Sanduleanu S, Rondagh EJ, Masclee AA. Development of expertise in the detection and classification of non polypoid colorectal neoplasia: Experience-based data at an academic GI unit. Gastrointestinal endoscopy clinics of North America. 2010;20(3):449-60. 51. Jover R, Zapater P, Polania E, . . . investigators Cs. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies. Gastrointest Endosc. 2013;77(3):381-9 e1. 52. le Clercq CM, Mooi RJ, Winkens B, . . . Sanduleanu S. Temporal trends and variability of colonoscopy performance in a gastroenterology practice. Endoscopy. 2016;48(3):248-55. 53. Waldmann E, Gessl I, Sallinger D, . . . Ferlitsch M. Trends in quality of screening colonoscopy in Austria. Endoscopy. 2016;48(12):1102-9. 54. Pilonis ND, Bugajski M, Wieszczy P, . . . Kaminski MF. Long Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy. Ann Intern Med. 2020;173(2):81-91. 55. Lam AY, Li Y, Gregory DL, . . . Keswani RN. Association between improved adenoma detection rates and interval colorectal cancer rates after a quality improvement program. Gastrointest Endosc. 2020;92(2):355-64 e5. 56. Castaneda D, Popov VB, Verheyen E, Wander P, Gross SA. New technologies improve adenoma detection rate, adenoma miss rate and polyp detection rate: a systematic review and meta-analysis. Gastrointest Endosc. 2018.

10

205